



※ 英文原著論文のみ掲載しています。
【 2009年 】
- Hamada Y, Fujii H, Kitazawa R, Yodoi J, Kitazawa S, Fukagawa M:
Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic oeteoporosis: A novel role of oxidative stress and therapeutic implications.
Bone 44: 936-941, 2009.
- Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drueke TB, Massy Z:
The calcimimetic R-568 retards progression of uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
Atherosclerosis, 205:55-62, 2009.
- Fujii H, Nishijima F, Goto S, Sugano M, Yamato H, Kitazawa R, Kitazawa S, Fukagawa M:
Oral charcoal adsorbent (AST-120) prevents the progression of cardiac damage in chronic kidney disease through the suppression of oxidative stress.
Nephrol Dial Transplant, 24:2089-2095, 2009.
- Sato T, Fukagawa M, Uchida K, Katayama A, Nagasaka T, Matsuoka S, Goto N, Tominaga Y, Kobeyashi T, Nakao A:
Pharmacokinetic target for ciclosporin A-based regimens in renal transplantation: Implications of maintaining 1,25-dihydroxyvitamin D3 synthesis.
Clin Transplant, 23:368-374, 2009.
- Fujii H, Kono K, Goto S, Onishi T, Kawai H, Hirata K, Hattori K, Nakamura K, Endo F, Fukagawa M.
Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease.
Am J Nephrol. 30:527-535, 2009.
